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Abstract
Background: Allogeneic red blood cell (RBC) transfusion has been proposed as a negative indicator of quality in
cardiac surgery. Hospital length of stay (LOS) may be a surrogate of poor outcome in transfused patients.
Methods: Data from 502 patients included in Transfusion Requirements After Cardiac Surgery (TRACS) study were
analyzed to assess the relationship between RBC transfusion and hospital LOS in patients undergoing cardiac
surgery and enrolled in the TRACS study.
Results: According to the status of RBC transfusion, patients were categorized into the following three groups:
1) 199 patients (40%) who did not receive RBC, 2) 241 patients (48%) who received 3 RBC units or fewer (low
transfusion requirement group), and 3) 62 patients (12%) who received more than 3 RBC units (high transfusion
requirement group). In a multivariable Cox proportional hazards model, the following factors were predictive of a
prolonged hospital length of stay: age higher than 65 years, EuroSCORE, valvular surgery, combined procedure,
LVEF lower than 40% and RBC transfusion of > 3 units.
Conclusion: RBC transfusion is an independent risk factor for increased LOS in patients undergoing cardiac surgery.
This finding highlights the adequacy of a restrictive transfusion therapy in patients undergoing cardiac surgery.
Trial registration: Clinicaltrials.gov identifier: NCT01021631.
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Background
The rationale for perioperative red blood cell (RBC)
transfusion is based on the observations that anemia is
an independent risk factor for morbidity and mortality
after cardiac surgery and that red blood cell transfusion
would benefit a subset of patients presenting tissue
hypoperfusion [1,2]. However, transfusions have been
associated with high rates of morbidity and mortality
in critically ill patients, and there is increasing evi-
dence for independent relationships between RBC transfu-
sion and infectious complications, cardiac and respiratory
morbidity, prolonged length of stay (LOS) and mortality
after cardiac surgery [2-4].
The Transfusion Requirements After Cardiac Surgery
(TRACS) study was a prospective, randomized, control-
led trial that recently demonstrated the safety of a re-
strictive strategy of transfusion compared with a liberal
strategy in patients undergoing elective cardiac surgery
[2]. In this study, independent of the adopted transfusion
strategy, the number of transfused RBC units was an in-
dependent risk factor for clinical complications and
death at 30 days [2].
The primary objective of this study was to assess
the relationship between RBC transfusion and hospital
length of stay in a large, single reference center of car-
diac surgery. Secondary objectives were to compare the
characteristics of patients who received RBC transfusion
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with those who did not, to evaluate the relationship of
the number of transfused RBC units with mortality and
clinical complications, and to identify the predictive fac-
tors for a prolonged hospital LOS. We hypothesized that
patients requiring early postoperative blood transfusion
would have longer hospital length of stay.
Methods
Study design
A detailed description of the TRACS study was re-
ported previously [2]. The TRACS study was designed
as a prospective, randomized, non-inferiority, controlled
trial (Additional file 1). Consecutive patients who were
scheduled for elective cardiac surgery with cardiopulmo-
nary bypass between February 9, 2009 and February 1,
2010, were enrolled. We included patients who under-
went elective coronary artery bypass graft (CABG) sur-
gery or cardiac valve replacement or repair, alone or in
combination (Additional file 1). The study was approved
by the the Heart Institute Ethics Committee, Clinics
Hospital, University of São Paulo, and written informed
consent was obtained from all patients before enrollment.
Patients were randomly assigned to a liberal or restrictive
transfusion strategy. Patients from the liberal strategy
group received RBC transfusions if their hematocrit values
were lower than 30% from the beginning of the surgery
until discharge from the ICU. Patients assigned to the re-
strictive strategy group received RBC transfusions if their
hematocrit values were lower than 24%. At the Heart In-
stitute, RBCs are separated from whole blood and stored
in a citrate solution without leukodepletion. In this study,
the median RBC unit storage time was 3 days.
In this substudy, we analyzed data from the overall
population of 502 patients included in the TRACS study.
Early postoperative RBC transfusion was defined as the
total number of RBC units administered during the first
72 postoperative hours, including the operative room
(Additional file 1). According to the number of units of
RBC transfusion, patients were further categorized into
the following three subgroups: 1) patients who did not
receive RBC transfusion, 2) patients who received 3 RBC
units or less (low transfusion group), and 3) patients
who received more than 3 RBC units (high transfusion
group). Hospital LOS was chosen as the primary out-
come variable because it incorporates the cumulative ef-
fect of postoperative complications previously associated
with blood transfusion.
Demographic data, intraoperative characteristics and
clinical outcomes were obtained as previously described,
and compared among groups [2].
Statistical analysis
We compared baseline characteristics, intraoperative data
and postoperative outcomes using Pearson’s chi-square
test. These results are expressed as absolute numbers and
as relative frequencies. The hospital length of stay is
expressed as the median and 95% confidence intervals,
assessed using a Kaplan Meier estimates curve. In addi-
tion, hospital length of stay is represented graphically as a
box plot. The boxes indicate the first quartile, the median,
and the third quartile. Open circles indicate the minor
outliers (observation 1.5 × interquartile range [IQR] out-
side the central box); asterisks indicate the major outliers
(observation 3.0 × IQR outside the central box). The asso-
ciation of preoperative and intraoperative factors with the
need for RBC transfusion was assessed in a univariate lo-
gistic regression model. An independent association be-
tween the transfusion category and the primary outcome
variable (LOS) was assessed using a Cox proportional ha-
zards model. Each of the candidate variables was chosen
from the univariate model for inclusion in the multivariate
analysis Cox proportional hazards model. The variables
that were independently associated with hospital LOS
were included in the final multivariate analysis. All of the
statistical tests were two-sided, and a p-value of less than
0.05 was considered statistically significant. These statis-
tical analyses were performed using SPSS version 18.0
(SPSS Inc., Chicago, Illinois).
Results
From the total of 502 patients randomized in the
TRACS study, 199 did not receive any RBC transfusion
(40%), 241 (48%) patients were given 1–3 units and 62
(12%) received more than 3 RBC units in the first 72
postoperative hours. Baseline characteristics of the groups
are compared in Table 1. Female gender, age higher than
65 years-old, redo surgery, higher European System for
Cardiac Operative Risk Evaluation (EuroSCORE) values
and renal disease were associated with exposure to RBC
transfusion. Other variables as preoperative left ventricu-
lar ejection fraction, heart failure, acute myocardial infarc-
tion, hypertension, diabetes, and unstable angina were not
associated with exposure to RBC units.
Intraoperative characteristics for the RBC transfusion
groups are compared in Table 1. As expected, a higher
proportion of patients from the liberal strategy group
received blood transfusion than did those from the re-
strictive strategy group (77% vs. 43%, p < 0.001). Most
patients underwent coronary bypass artery grafting
(CABG). Patients who were exposed to blood transfu-
sion had lower initial hematocrit and hemoglobin le-
vels compared to patients who did not receive RBC
transfusions.
From 502 patients, 236 (47%) patients received trans-
fusion at the operative room, 111 (22%) received at the
first postoperative day (1PO), 74 (15%) at the second
postoperative day (2PO) and 59 (12%) at the third post-
operative day (3PO) (Additional file 2).
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Analyzing postoperative clinical complications, pa-
tients who received RBC transfusion were more likely to
present major events related to the composite endpoint
(30-day all-cause mortality and cardiogenic shock, acute
respiratory distress syndrome, or acute kidney injury re-
quiring dialysis or hemofiltration, p < 0.001), in addition
to cardiac (p < 0.001), respiratory (p < 0.001), neurologic
(p = 0.014), infectious (p < 0.001), and inflammatory com-
plications (p < 0.001) (Figure 1). We also found that pa-
tients from the high transfusion group presented a higher
incidence of postoperative complications.
Length of stay analysis
The median hospital length of stay was 9 days (range, 1
to 67 days). Patients exposed to any RBC transfusion
had longer median length of stay than patients in the
non-transfusion group: 15 days [95% CI, 12–18] in high
transfusion requirement group (> 3 units) vs. 10 days
[95% CI, 9–11] in low transfusion requirement group
(1–3 units) vs. 9 days [95% CI, 8–10] in non-transfusion
group, p < 0.001) (Figure 2).
Many covariates had statistically significant associa-
tions with hospital LOS. These include: female gender,
older age, higher EuroSCORE, redo surgery, renal dis-
ease, lower initial hemoglobin and hematocrit, lower left
ventricular ejection fraction, renal disease, valvular sur-
gery or a combined procedure, longer cardiopulmonary
bypass, lower initial hemoglobin and hematocrit, and
exposure to RBC transfusion (Additional file 3 and
Additional file 4).
All variables significantly associated with increased
hospital length of stay were analyzed in a multivariate
Cox proportional hazards model. In the multivariate
model, the following factors were predictive of a pro-
longed hospital length of stay: age higher than 65 years
(hazard ratio [HR], 1.36 [95% CI, 1.09-1.7]; p = 0.006),
EuroSCORE higher than 3–5 (HR 1.46 [1.13-1.88]; p =
0.003, EuroSCORE higher than 5 (HR, 1.71 [95% CI,
Table 1 Baseline characteristics and intraoperative characteristics of patients according to the category of red blood
cell transfusion
Variable
Unit of RBC
None (N = 199) 1–3 units (N = 241) >3 units (N = 62) P
Gender (Female) 49 (24.6%) 114 (47.3%) 29 (46.8%) <0.001
Age (≥65 years) 57 (28.6%) 107 (44.4%) 30 (48.4%) 0.001
Redo surgery 3 (1.5%) 7 (2.9%) 14 (22.6%) <0.001
EuroSCORE
<3 126 (63.3%) 146 (60.6%) 35 (56.5%) <0.001
3–5 63 (31.7%) 78 (32.4%) 18 (29%)
>5 10 (5%) 17 (7.1%) 9 (14.5%)
Left ventricular ejection fraction (%)
<40 29 (14.6%) 31 (12.9%) 9 (14.5%) 0.738
40–59 53 (26.6%) 78 (32.4%) 20 (32.3%)
≥60 117 (58.8%) 132 (54.8%) 33 (53.2%)
Previous myocardial infarction 72 (36.2%) 80 (33.5%) 23 (37.7%) 0.755
Hypertension 159 (79.9%) 183 (75.9%) 51 (82.3%) 0.435
Diabetes 62 (31.2%) 75 (31.4%) 28 (45.9%) 0.075
Renal disease 15 (7.5%) 25 (10.7%) 12 (20.3%) 0.019
Unstable Angina 60 (30.2%) 74 (30.7%) 21 (33.9%) 0.855
Liberal RBC transfusion strategy 58 (29.1%) 147 (61%) 48 (77.4%) <0.001
Procedure
CABG 126 (63.3%) 146 (60.6%) 35 (56.5%) 0.164
Valve 63 (31.7%) 78 (32.4%) 18 (29%)
CABG + valve 10 (5%) 17 (7.1%) 9 (14.5%)
Cardiopulmonary bypass (>100 min) 59 (29.8%) 86 (35.8%) 27 (43.5%) 0.112
Initial hemoglobin (<13 g/dL) 64 (32.7%) 173 (72.7%) 51 (82.3%) <0.001
Initial hematocrit (<39%) 45 (23%) 151 (63.4%) 47 (75.8%) <0.001
Initial lactate (≥2 mmol/L) 55 (27.8%) 56 (23.5%) 10 (16.1%) 0.163
Initial SvcO2 (≥65%) 143 (87.2%) 163 (80.7%) 46 (83.6%) 0.248
Abbreviations: RBC, red blood cell transfusion;EuroSCORE, European System for Cardiac Operative Risk Evaluation; Redo, previous cardiac surgery, CABG, coronary
artery bypass surgery; SvcO2, central venous oxygen saturation; min: minutes; Initial = samples collected after the induction of anesthesia.
Galas et al. Journal of Cardiothoracic Surgery 2013, 8:54 Page 3 of 7
http://www.cardiothoracicsurgery.org/content/8/1/54
1.27–2.3]; p < 0.001), valvular surgery (HR, 1.60 [95% CI,
1.28–1.99]; p < 0.001), combined procedure (HR, 1.73
[95% CI, 1.12–2.67]; p = 0.013), LVEF lower than 40%
(HR, 1.63 [95% CI, 1.19-2.24]; p = 0.002), LVEF 40–59%
(HR, 1.32 [95% CI, 1.07–1.64]; p = 0.001), and RBC
transfusion of > 3 units (HR, 2 [95% CI, 1.44–2.79]; p <
0.001) (Table 2).
In an adjusted model for age, EuroSCORE, type of
surgical procedure and left ventricular ejection fraction,
the exposure to RBC transfusion was associated with a
prolonged hospital length of stay (Figure 3).
Discussion
In this study of 502 patients undergoing elective cardiac
surgery, we found that 60% received RBC within the first
72 postoperative hours. Patients requiring RBC transfu-
sion were older, most of them were female, underwent
redo and complex surgeries, had higher EuroSCORE,
presented with lower levels of hemoglobin and hemato-
crit and had a higher incidence of renal disease. In a
multivariable model adjusted for univariate associations,
RBC transfusion was a predictor of longer hospital length
of stay, and the strongest association was found in the
high transfusion group. Independent of the strategy of
transfusion, patients who received RBC transfusion in the
first 72 postoperative hours had a higher incidence of
complications, including renal failure, cardiogenic shock,
acute respiratory distress syndrome, infectious, neuro-
logic and inflammatory complications and longer hos-
pital length of stay.
Figure 1 Complications according to category of red blood cell
transfusion. RBC: red blood cell.
Figure 2 Box plots of hospital length of stay (LOS), according
to category of red blood cell transfusion. RBC: red blood cell. The
boxes indicate the first quartile, the median, and the third quartile.
Open circles indicate minor outliers (observation 1.5 × interquartile
range [IQR] outside the central box); asterisks indicate major outliers
(observation 3.0 × IQR outside the central box).
Table 2 Multivariate cox proportional hazard model for
length of hospital stay
Variable
Hazard ratio
p
(95% CI)
Age (years)
<65 Reference
≥65 1.36 (1.09 – 1.7) 0.006
EuroSCORE
<3 Reference
3–5 1.46 (1.13 – 1.88) 0.003
>5 1.71 (1.27 – 2.3) <0.001
Procedure
CABG Reference
Valve 1.6 (1.28 – 1.99) <0.001
CABG + valve 1.73 (1.12 – 2.67) 0.013
Left ventricular ejection fraction (%)
<40 1.63 (1.19 – 2.24) 0.002
40–59 1.32 (1.07 – 1.64) 0.010
≥60 Reference
Units of RBC transfused
None Reference
Low-transfusion (1–3 units) 1.16 (0.94 – 1.42) 0.164
High-transfusion (>3 units) 2.00 (1.44 – 2.79) <0.001
Abbreviations: CI, confidence interval; CABG, coronary artery bypass graft
surgery; min, minutes; RBC; red blood cells.
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Significant variability in transfusion practice exists in
cardiac surgery. A recent analysis [5] of blood practices
across 798 US hospitals drew attention to this problem.
In hospitals performing at least 100 on-pump CABG
operations (82 446 cases), rates of blood transfusion
ranged from 7.8% to 92.8% for RBCs, 0% to 97.5% for
fresh-frozen plasma, and 0.4% to 90.4% for platelets.
Multivariable analysis revealed that after adjustment
for patient-level risk factors, hospital transfusion rates
varied by geographic location (P = .007), academic sta-
tus (P = .03), and hospital volume (P < .001).
We found patients who were female, older, underwent
redo or complex surgeries, as well as those who had
higher EuroSCORE, renal disease, or previous anemia,
were more likely to receive RBC transfusion. This find-
ing emphasizes the need to maximize efforts to improve
perioperative care in these subgroups of patients in
order to avert RBC transfusion adverse events, including
increased hospital length of stay.
Rates of transfusion persist high after cardiac surgery
despite studies showing that RBC transfusion does not
result in better outcomes and even increases rates of
complications after cardiac surgery [6]. Guidelines from
the Society of Thoracic Surgeons and Society of Cardio-
vascular Anesthesiologists emphasize the lack of evi-
dence on transfusion triggers after cardiac surgery [7].
Most transfusion indications occur in the first 72 hours
after surgery, starting in the operating room, where usu-
ally the transfusion indication is due to hemodilution
and based on triggers [2].
The rationale for implementing a restrictive transfu-
sion strategy is based on analysis of studies reporting a
Figure 3 Box plot indicating the prolonged hospital length of stay according to category of red blood cell transfusion for each of the
risk factors: (A) age, (B) EuroSCORE, (C) procedure and (D) left ventricular ejection fraction. RBC: red blood cell; EuroSCORE: European
System for Cardiac Operative Risk Evaluation.
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lack of benefit and, at the same time, substantially in-
creased costs and adverse effects associated with RBC
transfusion. These adverse effects include acute hemolytic
and nonhemolytic reactions, transmission of viral and bac-
terial diseases, transfusion-related acute lung injury, and
transfusion-associated circulatory overload [8]. Immuno-
suppression has also been associated with transfusion and
may explain the higher risk of infection and recurrence of
neoplastic diseases observed in transfused patients [9].
In a retrospective analysis of 11, 963 patients who un-
derwent isolated CABG surgery, Koch et al [10] showed
that perioperative RBC transfusion was associated with a
dose-dependent increased risk of postoperative cardiac
complications, serious infection, renal failure, neurologic
complications, overall morbidity, prolonged ventilator
support, and in-hospital mortality. In a similar retrospect-
ive study, Murphy et al [11] showed that RBC transfusion
was strongly associated with infection and with postopera-
tive ischemic morbidity, hospital stay, increased early and
late mortality, and hospital costs.
Recently, the TRACS study prospectively demon-
strated the safety of a restrictive strategy of RBC trans-
fusion in patients undergoing cardiac surgery [2]. Also,
this study reported that the higher the number of trans-
fused RBC, the higher was the number of clinical com-
plications [2].
In our study, we found that patients exposed to RBC
transfusion had more complications when compared to
patients not exposed, a similar result described in previ-
ous reports [1-4,6,10]. The evaluation of mechanisms re-
lated to RBC transfusion that results in morbidity were
not included in this study. However, our hypothesis it
that these potential effects may underlie the independent
association between blood transfusion and prolonged
LOS. On univariate comparison, total length of stay was
approximately 6 days longer in the population of pa-
tients who received more than 3 RBC units of transfu-
sion and 1 day longer in patients receiving until 3 units
as compared to non-exposed group. Multivariate ana-
lysis demonstrated a significant relationship between early
postoperative transfusion (more than 3 units of RBC) and
longer hospital stay.
De Cocker et al [12]. performed a retrospective
analysis of 1566 patients undergoing cardiac surgery
and identified age greater than 75 years, female gender,
NYHA functional class greater than II, arrhythmias, mi-
tral regurgitation, need for inotropic support or intra-
aortic balloon pump, non-elective procedures and aortic
surgery as predictive factors for a prolonged ICU stay
[12]. However, in this study, blood transfusion was not
evaluated as a potential predictor of increased hospital
LOS [12].
Prolonged hospital LOS is being studied because it
results in increased costs, and clinical complications as
exposure to infectious agents. It constitutes a possible
method to estimate complications after cardiac surgery
[13]. Several models have been developed to predict pro-
longed stay after cardiac surgery. In our practice, the
EuroSCORE is widely applied to predict both mortality
and prolonged hospital stay [14,15]. Our findings incorp-
orate RBC transfusion higher than 3 units after cardiac
surgery as a strong predictor of prolonged LOS. Also,
age higher than 65 years, valvular surgery or a combined
procedure, left ventricular ejection fraction lower than
60% were also predictors of increased hospital length of
stay, as have been previously reported [15].
Limitations of our study include that it was performed
in a single referral center for cardiac surgery, which
could compromise the generalizability of our findings.
Also, the associations we found between RBC transfu-
sion and longer LOS do not explain causality due to the
fact of RBC transfusion may only be a surrogate marker
of perioperative complications or higher morbidity. In
fact, older and sicker patients with more debilitating
conditions were stratified into the transfusion group and
it may lead to a misinterpretation. So, it is possible that
other variables with impact LOS and not included in the
results, may not have been present in the multivariable
model. Moreover, the present study is a retrospective
analysis from a previous randomized clinical trial with a
dictated trigger. Retrospective studies are best done in a
large cohort of consecutive unselected patients which
could limit our interpretation.
Conclusion
The increased length of hospital stay related to the num-
ber of transfused RBC units supports a restrictive ther-
apy in cardiac surgery. In addition, clinicians caring for
patients after cardiac surgery should administer only 1
RBC unit at a time, because this may result in less ex-
posure to risks but similar benefits.
Importantly, although the interpretation of our data
must take account the restrictions of the substudy ana-
lysis, our results brings additional information regarding
an independent association of early RBC transfusion
with longer hospital stay.
Additional files
Additional file 1: Flowchart of screened, excluded and included
patients. TRACS: Transfusion Requirements after Cardiac Surgery; RBC:
red blood cells. *Ten patients were excluded after consent was obtained
because of a change in surgical plan (i.e., surgery was performed without
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Additional file 2: Distribution of the percentage of transfusions
according to postoperative day. Intraop: intraoperatory period,
PO: postoperative period.
Additional file 3: Preoperative Characteristics Associated with
Increased Hospital Length of Stay.
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